Current status of pathological image analysis technology in pharmaceutical companies: a questionnaire survey of the Japan Pharmaceutical Manufacturers Association

The Japan Pharmaceutical Manufacturers Association (JPMA) has instituted a task force (TF) for the “development of image analysis technology for histopathological changes” as part of the collaboration for realizing cutting-edge drug development since 2016. In recent years, there has been progress in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshikawa, Tsuyoshi, Horai, Yasushi, Asaoka, Yoshiji, Sakurai, Takanobu, Kikuchi, Satomi, Yamaoka, Makiko, Tanaka, Masaharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Toxicologic Pathology 2020
Materias:
Technical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218240/
https://www.ncbi.nlm.nih.gov/pubmed/32425346
http://dx.doi.org/10.1293/tox.2019-0056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218240/
https://www.ncbi.nlm.nih.gov/pubmed/32425346
http://dx.doi.org/10.1293/tox.2019-0056

Ejemplares similares